CpG island methylator phenotype redefines the prognostic effect of t(12;21) in childhood acute lymphoblastic leukemia

Clinical Cancer Research

Volumn 12, Issue 16, 2006, Pages 4845-4850

  Roman Gomez, Jose ^a,d   Jimenez Velasco, Antonio ^b   Agirre, Xabier ^c   Castillejo, Juan A ^a   Navarro, German ^b   Calasanz, Maria J ^c   Garate, Leire ^c   San Jose Eneriz, Edurne ^c   Cordeu, Lucia ^c   Prosper, Felipe ^c   Heiniger, Anabel ^b   Torres, Antonio ^a  

^a Reina Sofia Hospital   (Argentina)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

^d HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P73; TRANSCRIPTION FACTOR RUNX1;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER REGRESSION; CANCER SURVIVAL; CELL IMMORTALIZATION; CHILD; CONTROLLED STUDY; CPG ISLAND; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; METHYLATION; MULTIVARIATE ANALYSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 21; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CPG ISLANDS; DNA METHYLATION; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; ONCOGENE PROTEINS, FUSION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTO-ONCOGENE PROTEINS C-ETS; REPRESSOR PROTEINS; TRANSLOCATION, GENETIC;

EID: 33745123035     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-2592     Document Type: Article

References (28)

1. Loh ML, Rubnitz JE. TEL/AML1-positive pediatric leukemia: prognostic significance and therapeutic approaches. Curr Opin Hematol 2002;9:345-52.
2. McLean TW, Ringold S, Neuberg D, et al. TEL/AML1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood 1996;88:4252-8.
3. Borkhardt A, Cazzaniga G, Viehmann S, et al. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Munster Study Group. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Blood 1997;90:571-7.
4. Harbott J, Viehmann S, Borkhardt A, Henze G, Lampert F. Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse. Blood 1997;90:4933-7.
5. Seeger K, Adams HP, Buchwald D, et al. TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. The Berlin-Frankfurt-Munster Study Group. Blood 1998;91:1716-22.
6. Ford AM, Fasching K, Panzer-Grumayer ER, Koenig M, Hass OA, Greaves MF. Origins of "late" relapse in childhood acute lymphoblastic leukemia with TEL-AML1 fusion gene. Blood 2001;98:558-64.
7. Weston VJ, McConville CM, Mann JR, et al. Molecular analysis of single colonies reveals a diverse origin of initial clonal proliferation in B-precursor acute lymphoblastic leukemia that can precede the t(12;21) translocation. Cancer Res 2001;61:8547-53.
8. Sawinska M, Ladon D. Mechanism, detection and clinical significance of the reciprocal translocation t(12;21)(p12;q22) in the children suffering from acute lymphoblastic leukaemia. Leuk Res 2004;28:35-42.
9. Alvarez Y, Coll MD, Ortega JJ, et al. Genetic abnormalities associated with the t(12;21) and their impact in the outcome of 56 patients with B-precursor acute lymphoblastic leukemia. Cancer Genet Cytogenet 2005;162:21-9.
10. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002;16:6-21.
11. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003;349:2042-54.
12. Esteller M. Relevance of DNA methylation in the management of cancer. Lancet Oncol 2003;4:351-8.
13. Roman-Gomez J, Jimenez-Velasco A, Castillejo JA, et al. Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia. Blood 2004;104:2492-8.
14. Roman-Gomez J, Jimenez-Velasco A, Agirre X, Prosper F, Heiniger A, Torres A. Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis. J Clin Oncol 2005;23:7043-9.
15. Ortega JJ. Spanish acute lymphoblastic leukemia trials. Int J Pediatr Hematol Oncol 1998;5:163-76.
16. Ribera JM, Ortega JJ, Oriol A, et al. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial. Haematologica 2002;87:154-66.
17. Elhasid R, Sahar D, Merling A, et al. Mitochondrial pro-apoptotic ARTS protein is lost in the majority of acute lymphoblastic leukemia patients. Oncogene 2004;23:5468-75.
18. Izumi H, Inoue J, Yokoi S, et al. Frequent silencing of DBC1 is by genetic or epigenetic mechanisms in non-small cell lung cancers. Hum Mol Genet 2005;14:997-1007.
19. Iwai M, Kiyoi H, Ozeki K, et al. Expression and methylation status of the FHIT gene in acute myeloid leukemia and myelodisplastic syndrome. Leukemia 2005;19:1367-75.
20. Rothem L, Stark M, Kaufman Y, Mayo L, Assaraf YG. Reduced folate carrier gene silencing in multiple antifolate-resistant tumor cell lines is due to a simultaneous loss of function of multiple transcription factors but not promoter methylation. J Biol Chem 2004;279:374-84.
21. Liu ZJ, Zhang XB, Zhang Y, Yang X. Progesterone receptor gene inactivation and CpG island hypermethylation in human leukemia cancer cells. FEBS Lett 2004;567:327-32.
22. Takahashi T, Suzuki M, Shigematsu H, et al. Aberrant methylation of Reprimo in human malignancies. Int J Cancer 2005;115:503-10.
23. Matsushita C, Yang Y, Takeuchi S, et al. Aberrant methylation in promoter-associated CpG islands of multiple genes in relapsed childhood acute lymphoblastic leukemia. Oncol Rep 2004;12:97-9.
24. Schar P, Fasi M, Jessberger R. SMC1 coordinated DNA double-strand break repair pathways. Nucleic Acids Res 2004;32:3921-9.
25. Takeuchi S, Bartram CR, Wada M, et al. Allelotype analysis of childhood acute lymphoblastic leukemia. Cancer Res 1995;55:5377-82.
26. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996;93:9821-6.
27. Morrow M, Horton S, Kioussis D, Brady HJ, Williams O. TEL-AML1 promotes development of specific hematopoietic lineages consistent with preleukemic activity. Blood 2004;103:3890-6.
28. Fine BM, Stanulla M, Schrappe M, et al. Gene expression patterns associated with recurrent chromosomal translocation in acute lymphoblastic leukemia. Blood 2004;103:1043-9.